ENYO Pharma raises $24.4 mln in Series A funding
ENYO Pharma, a biopharmaceutical company developing treatments for viral infections, raised 22 million euros ($24.4 million) in Series A financing. Returning investor Sofinnova Partners led the round with participation from Morningside and Bpifrance.
3 February 2016•3 mins read
